This is a competing continuation application for renewal of a training program in cardiovascular research that was first funded in 1979. Since the last competitive renewal, 14 trainees have been supported of whom all are in full time academic positions, full-time research in industry, or still in training. Three have garnered independent extramural funding, and 3 hold faculty positions. The goal of this program is to train young researchers committed to careers in investigative cardiology or allied fields, and to provide them with the skills needed for success in modern multi-disciplinary research environments encompassing basic, translational and/or clinical research. Trainees may be MDs, MD-PhDs or PhDs who have finished clinical or graduate training and are seeking further research training in cardiology. Important elements of the curriculum are supervision by faculty advisors, """"""""team mentors"""""""" to provide multiple perspectives on career and research decisions, individualized and common didactic curricula, formal meclianisms for bi-directional feedback and communication, as well as clearly defined expectations and milestones for trainees and mentors. Dr. Anthony Rosenzweig is the Program Director and Drs. Murray Mittleman and Peter Oettgen are the Associate Program Directors, providing senior leadership from diverse disciplines with a longstanding commitment to mentoring. A Steering Committee comprised of basic and clinical faculty selects trainees from a large pool of candidates, and monitors individual and programmatic progress. An External Advisory Committee ensures that the program remains current and responsive to rapid changes in the researching environment. The training program benefits from strong institutional support and infrastructure, including those within the Cardiovascular Division, the Department of Medicine, Harvard Medical School, and the Harvard School of Public Health. The recently funded Harvard Medical School Clinical and Translational Science Award have further enhanced research, training,, and didactic opportunities in clinical and translational investigator. The BIDMC Cardiovascular Division, in general, and this T32 Training Grant, in particular, has a long and successful track record of training clinical and basic investigators. With this application, we seek to continue and enhance this tradition.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007374-36
Application #
8716794
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Wang, Wayne C
Project Start
1994-07-01
Project End
2015-07-31
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
36
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02215
Kim, Dae Hyun; Kim, Caroline A; Placide, Sebastian et al. (2016) Preoperative Frailty Assessment and Outcomes at 6 Months or Later in Older Adults Undergoing Cardiac Surgical Procedures: A Systematic Review. Ann Intern Med 165:650-660
Santos, Angela B S; Gupta, Deepak K; Bello, Natalie A et al. (2016) Prehypertension is Associated With Abnormalities of Cardiac Structure and Function in the Atherosclerosis Risk in Communities Study. Am J Hypertens 29:568-74
Jang, Cholsoon; Oh, Sungwhan F; Wada, Shogo et al. (2016) A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nat Med 22:421-6
Gori, Mauro; Gupta, Deepak K; Claggett, Brian et al. (2016) Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 39:677-85
Lerchenmüller, Carolin; Heißenberg, Julian; Damilano, Federico et al. (2016) S100A6 Regulates Endothelial Cell Cycle Progression by Attenuating Antiproliferative Signal Transducers and Activators of Transcription 1 Signaling. Arterioscler Thromb Vasc Biol 36:1854-67
Bello, Natalie A; Lewis, Eldrin F; Desai, Akshay S et al. (2015) Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease. Eur J Heart Fail 17:1201-7
Wei, Xin; Liu, Xiaojun; Rosenzweig, Anthony (2015) What do we know about the cardiac benefits of exercise? Trends Cardiovasc Med 25:529-36
Hinson, John T; Chopra, Anant; Nafissi, Navid et al. (2015) HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Science 349:982-6
Liu, Xiaojun; Xiao, Junjie; Zhu, Han et al. (2015) miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell Metab 21:584-95
Kim, Caroline A; Kim, Dae Hyun (2015) Statins Provide Less Benefit in Populations with High Noncardiovascular Mortality Risk: Meta-Regression of Randomized Controlled Trials. J Am Geriatr Soc 63:1413-9

Showing the most recent 10 out of 141 publications